Loading...
OTC Markets
Totals
Securities
12,306
Dollar Vol
$2.0B
Share Vol
4B
Trades
367,183

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

AVCRF
Avricore Health Inc.

Ordinary Shares

0.04774

-0.00626

-11.59%

0.0543 / 0.0594 (25000 x 20000)

Real-Time Best Bid & Ask: 05:00pm 07/11/2025
Delayed (15 Min) Trade Data: 12:00am 07/11/2025
Avricore Health Inc. Company Logo

1120-789 West Pender St

Vancouver, BC V6C 1H2

Canada

Principal Executive Offices:

1120 - 789 West Pender Street

Vancouver, BC V6C 1H2

Canada

Business Description
Avricore Health Inc. is committed to becoming a health innovator and applying technologies at the forefront of science to core health issues at the community pharmacy level. The Company's goal is to empower consumers, patients and pharmacists with innovative technology, products, services and information to monitor and optimize health.
Financial Reporting
Reporting Status
U.S. Reporting: SEC Reporting
Audited Financials
Audited
CIK
0001355736
Fiscal Year End
12/31
Company Officers & Contacts
Kiki Smith
CFO

Rodger Seccombe
CTO, CEO

Rae Mancao
Accountant

Muhammad Mujeeb Memon
Controller

Board of Directors
David Hall
Chairman, Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member

Alan Arnstein
Independent Director, Audit Committee Member

Christine Hrudka
Independent Director, Audit Committee Member

Rodger Seccombe
CTO, CEO

Robert Sindelar
Independent Director, Compensation Committee Member, Nominating Committee Member

Thomas Teahen
Independent Director, Compensation Committee Member, Nominating Committee Member

Other Company Insiders

None

Other Company Insiders are all persons or entities beneficially owning 10% or more of any class of the issuer's securities. Together, officers, directors and other company insiders comprise Company Insiders.
Service Providers
Accounting/Auditing Firm
Manning Elliott LLP

17th Floor, 1030 West Georgie St,,

Vancouver, BC V6E 2Y3

Canada

Securities Counsel
Max Pinsky Personal Law Corporation

1199 West Hastings Street

Suite 700

Vancouver, BC V6E 3T5

Canada

Profile Data
SIC - Industry Classification
2834 - Pharmaceutical preparations
Incorporation Information
BC, CA, 2000
Employees
10 as of 04/09/2024
Shell
No
Products and Services

Avricore is a total health innovator capitalizing on technological advancements and consumer health trends, offering consumers and health providers the ability to take control of spending and health outcomes. There are many stakeholders who have a role to play in better health outcomes and better data will ensure they can fulfill their objectives. The HealthTab + Rastr Network supports them and makes it possible. The RASTR Network is the first point-of-care based system which provides direct consumer consent on targeted patient demographics, as well as harmonized, real-time reporting on customized data. Real-time monitoring makes remote care delivery and follow-ups easier. Our solution can integrate seamlessly into patient heath records, allowing for results of testing to be remotely monitored in real-time. The HealthTab screen test means you can track patient progress, adherence and make evidence-based decisions on treatment recommendations.

Company Facilities

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward. Through its flagship offering HealthTab™, a wholly owned subsidiary, the company’s mission is to make actionable health information more accessible to everyone by creating the world’s largest network of rapid testing devices in community pharmacies. HealthTab™ is a turnkey point-of-care testing solution that combines best-in-class point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). HealthTab™ has also recently added capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab™ network gives knowledgeable and trusted pharmacists a greater role in primary care delivery, while empowering patients to take more control of their health. It also reduces costs and waiting times and provides many potential revenue streams including equipment leasing & consumables, direct access testing, disease prevention & management programs, sponsored health programs, decentralized clinical trials, real world data (RWD) sets, and third-party app integration through API.

Company Notes
Formerly=Vanc Pharmaceuticals, Inc. until 11-2018
Formerly=Nuva Pharmaceuticals Inc. until 8-2014
Formerly=Alda Pharmaceuticals Corp. until 7-2013
OTCQB Venture Market Logo
Joined OTCQB 03/2023
The Company Profile data was verified by the issuer within the previous 6 months.
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
The Company’s board of directors includes at least two Independent Directors.
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.